# GSK-spinoff Haleon forecasts 2023 organic revenue growth at top-end of view
Author: Pal sinha, Barnali
Author URL: https://startupobserver.com/author/pal-sinha-barnali/
Published: 2023-04-20
Category: Headlines
Category URL: https://startupobserver.com/category/headlines/
Meta Title: GSK-spinoff Haleon forecasts strong 2023 revenue growth
Meta Description: Consumer healthcare giant Haleon expects organic revenue to grow at the upper end of its forecast due to high demand for respiratory products.
URL: https://startupobserver.com/gsk-spinoff-haleon-forecasts-2023-organic-revenue-growth-at-top-end-of-view/

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qsrmdo0032wirgrt84jr62/images/2023-04-20t064720z2lynxmpej3j07mrtroptp4usa-stocks-1737046136963-compressed.jpg)

(Reuters) – Consumer healthcare group Haleon expects 2023 organic revenue growth towards the upper end of its 4%-6% forecast, it said on Thursday, on strong demand and the restocking of its respiratory health products due to a bad cold and flu season.

The company, the world’s biggest standalone consumer health business that sells non-prescription drugs, vitamins and oral care products, kept the rest of its full-year 2023 outlook unchanged.

Haleon was carved out of British drugmaker GSK in July last year.

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Janane Venkatraman)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---